Medicines not recommended for use in NHS Grampian
Click here to view SMC "not recommended" statements for products where submissions have not been made.
Rimonabant - non-formulary. Rimonabant (Acomplia®) was launched at the end of June.
SMC received a submission from Sanofi in October. Advice should be available from SMC and then Formulary Group next year (Q1/2 2007).